Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

121
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
121
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

105
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
105
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

351
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
351
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

363
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
363
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

17
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
17
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

161
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
161

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Capsule Endoscopy for Treat-to-Target Monitoring in Crohn's Disease: A Systematic Review and Meta-Analysis.

Gastrointestinal endoscopy·2026
Same author

Congenital Esophageal Stenosis Presenting During Weaning in a 5-Month-Old Infant.

Children (Basel, Switzerland)·2026
Same author

Risk factors for oral and esophageal candidiasis during budesonide treatment in eosinophilic esophagitis patients.

Internal and emergency medicine·2026
Same author

Empirical first- and second-line eradication regimens for Helicobacter pylori adult-infected patients: a National Survey among Italian gastroenterologists and general practitioners.

European journal of gastroenterology & hepatology·2026
Same author

Impact of Red Pack Cell Transfusion Before or After Endoscopy on Mortality in Patients with Upper Gastrointestinal Bleeding: A Multicenter Cohort Study.

Diseases (Basel, Switzerland)·2025
Same author

Bone in emergency room: Not only a skeletal problem! A rare case of accidental chicken bone ingestion in the afferent loop following Billroth II partial gastrectomy.

Radiology case reports·2025

Related Experiment Video

Updated: Aug 3, 2025

Author Spotlight: Point-of-Care Ultrasound for Gastric Content Assessment and Risk Stratification in Perioperative Care
05:50

Author Spotlight: Point-of-Care Ultrasound for Gastric Content Assessment and Risk Stratification in Perioperative Care

Published on: September 22, 2023

3.0K

Defining Time in Acute Upper Gastrointestinal Bleeding: When Should We Start the Clock?

Riccardo Marmo1, Marco Soncini2, Cristina Bucci3

  • 1Gastroenterology and Endoscopy Unit, "L. Curto" Hospital Polla, ASL Salerno, 84025 Polla, Italy.

Journal of Clinical Medicine
|April 13, 2023
PubMed
Summary

Accurate timing for upper endoscopy in upper gastrointestinal bleeding (UGIB) is crucial. The symptoms-to-endoscopy timeframe more accurately predicts mortality risk than presentation-to-endoscopy, suggesting a need for revised timing definitions in UGIB patient management.

Keywords:
acute gastrointestinal bleedingmortalitypredictionscoring risktiming to endoscopy

More Related Videos

Uncontrolled Hemorrhagic Shock Modeled via Liver Laceration in Mice with Real Time Hemodynamic Monitoring
06:11

Uncontrolled Hemorrhagic Shock Modeled via Liver Laceration in Mice with Real Time Hemodynamic Monitoring

Published on: May 21, 2017

8.7K
Author Spotlight: Advancing Spectral Characterization of Physiological and Malperfused Tissues
04:57

Author Spotlight: Advancing Spectral Characterization of Physiological and Malperfused Tissues

Published on: July 5, 2024

508

Related Experiment Videos

Last Updated: Aug 3, 2025

Author Spotlight: Point-of-Care Ultrasound for Gastric Content Assessment and Risk Stratification in Perioperative Care
05:50

Author Spotlight: Point-of-Care Ultrasound for Gastric Content Assessment and Risk Stratification in Perioperative Care

Published on: September 22, 2023

3.0K
Uncontrolled Hemorrhagic Shock Modeled via Liver Laceration in Mice with Real Time Hemodynamic Monitoring
06:11

Uncontrolled Hemorrhagic Shock Modeled via Liver Laceration in Mice with Real Time Hemodynamic Monitoring

Published on: May 21, 2017

8.7K
Author Spotlight: Advancing Spectral Characterization of Physiological and Malperfused Tissues
04:57

Author Spotlight: Advancing Spectral Characterization of Physiological and Malperfused Tissues

Published on: July 5, 2024

508

Area of Science:

  • Gastroenterology
  • Clinical Outcomes Research
  • Medical Timing Standards

Background:

  • Optimal timing of upper endoscopy is critical for managing patients with upper gastrointestinal bleeding (UGIB).
  • Current definitions of endoscopic examination timing in UGIB are imprecise.
  • The impact of different timing definitions on patient mortality requires clarification.

Purpose of the Study:

  • To determine if symptoms-to-endoscopy and presentation-to-endoscopy timeframes affect mortality in UGIB patients.
  • To assess the similarity between these two distinct timing measurements.

Main Methods:

  • A post-hoc analysis of a prospective, multicenter cohort study involving 50 Italian hospitals.
  • Inclusion of 3324 UGIB patients with complete time data for 3166.
  • Collection of demographic, organizational, clinical data, and outcomes, focusing on endoscopy timing.

Main Results:

  • A significant 9.2-hour difference was observed between symptoms-to-endoscopy and presentation-to-endoscopy timeframes (p < 0.001).
  • The symptoms-to-endoscopy timeframe showed a different death risk profile and significantly improved mortality risk prediction (p < 0.0002).
  • Moderate similarity was found between the two timeframes (K = 0.42 ± 0.01; p < 0.001).

Conclusions:

  • Symptoms-to-endoscopy and presentation-to-endoscopy represent distinct timings in UGIB patient management.
  • The symptoms-to-endoscopy timeframe is more accurate in identifying patient mortality risk.
  • Further studies are recommended to validate these findings and potentially adopt a revised definition of time for endoscopy in UGIB.